← Company intelligence

Robot maker · registered

Virtual Incision

Corporate marketmedicalCurated record

Builds MIRA (Miniaturized In vivo Robotic Assistant), the first miniaturized robotic-assisted surgery device to receive FDA marketing authorization (De Novo pathway, February 2024, colectomy indication). The ~2 lb self-contained surgical robot is inserted through a single midline umbilical incision and is portable enough to make any OR robot-ready in minutes, versus mainframe surgical robots. Spun out of University of Nebraska research by Shane Farritor and surgeon Dmitry Oleynikov; the platform is AI-enabled (featured at NVIDIA GTC; exploring NVIDIA Isaac for Healthcare) and was used in a U.S. remote robotic-assisted surgery demonstration in November 2024 with Sovato, City of Hope and University of Illinois Chicago. Commercialization began via a First Access Program at select U.S. centers, with gynecology, general surgery and urology indications in the pipeline.

HeadquartersLincoln, US
Founded2006
Corporate fundingNot disclosed
TeamNot listed
Deployments2
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries C (extended)
FoundersShane Farritor (Co-Founder), Dmitry Oleynikov (Co-Founder)
Regions servedNorth America, Europe
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-21
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

MIRA Surgical System

  • Approximately two-pound miniaturized robotic-assisted surgery device inserted through a single midline umbilical incision in the abdomen

    Device weight and single-incision surgical access approach

    Claim source
  • First miniaturized robotic-assisted surgery device to receive FDA marketing authorization (De Novo pathway, colectomy indication in adults)

    Regulatory status and cleared indication

    Claim source
  • Portable design with minimal setup time, intended to make any operating room robot-ready within minutes

    Deployment footprint versus mainframe surgical robots

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2024-07-30Geneva University Hospitalshospital (first hysterectomy with MIRA; international prospective clinical study)CHNot disclosedAnnouncement
2021-08-16Bryan Medical Centerhospital (IDE clinical study, world-first MIRA surgery)USNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordEndeavour VisionBaird CapitalBluestem Capitalcultivate(MD) Capital FundsPrairieGold Venture PartnersArboretum Ventures
TL

Company timeline

Milestones and announcements

2024-02-24FDA grants De Novo marketing authorization for MIRA, the first miniaturized robotic-assisted surgery device (colectomy indication); commercialization begins via First Access Program at select U.S. centersVirtual Incision
2021-08-16World's first surgery with the MIRA platform: robotically assisted right hemicolectomy performed by Dr. Michael A. Jobst at Bryan Medical Center under an FDA Investigational Device ExemptionBusiness Wire
SC

Source ledger

6 unique public sources